The global high-flow nasal cannula market can be divided on the basis of components into air/oxygen blender, nasal cannulas, active humidifier, single heated tube, and other consumables. The segment of active humidifier, among them, accounted for a leading share in the market in 2016. In the next couple of years too, active humidifiers are predicted to hold on to their leading shares because of continued innovations in humidifiers by manufacturers and health care solution providers in order to up their efficacy.
Geographically, the key segments of the global high-flow nasal cannula market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among them, North America accounts for maximum market share market owing to a growing patient base suffering from respiratory diseases. Apart from that, lower prices, awareness and helpful healthcare and reimbursement policies are also benefitting the market majorly. By registering an 11.2% CAGR between 2017 and 2025, the market in the region is predicted to grow its dominant share further. The TMR report expects the market to rake in a revenue of US$3.91 bn by 2025.
Some of the prominent participants in the global high-flow nasal cannula market are Fisher & Paykel Healthcare Limited, ResMed, Inc., Teijin Pharma Limited, Becton, Dickinson and Company, MEK-ICS CO., LTD., Teleflex Incorporated, Smiths Medical, Vapotherm, Inc., Flexicare Medical Limited, Salter Labs, Hamilton Medical, TNI medical AG, and Great Group Medical Co., Ltd. Of them, Fisher & Paykel Healthcare Limited emerged as the market leader in 2016.
As per a study by Transparency Market Research, the global high-flow nasal cannula market will expand at a steady pace in the upcoming years. The report estimates that the market was worth US$3.42 bn 2016. Rising at a solid CAGR of 11.8% during the period between 2017 and 2025, the market will likely attain a value of US$9.08 bn by 2025, it predicts.